1.	Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: SG 327/10, NCT01402089
2.	Quality Study of Anesthetic Technique on Breast Cancer Surgery Phase: Phase IV Type: Supportive care Status: Approved-not yet active Age: 18 to 70 Sponsor: Other Protocol IDs: 20110920A, NCT01499836
3.	Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2009-08-037, NCT01157598
4.	Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients Phase: Phase II Type: Supportive care Status: Active Age: 19 and over Sponsor: Other Protocol IDs: FHREB 2012-057, NCT01687751
5.	To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CAMN107A2128, 2009-009425-28, NCT01223898
6.	Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects Phase: Phase I Type: Biomarker/Laboratory analysis Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: ARQ197-A-U158, NCT01517399
7.	Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CTKI258A2119, 2011-001489-16, NCT01596647
8.	A Study of LY3023414 in Participants With Advanced Cancer Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13517, I6A-MC-CBBA, NCT01655225
9.	The Effect of Adding Intraoperative Regional Anesthesia on Cancer Recurrence in Patients Undergoing Lung Cancer Resection Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: 10-610, NCT01179308
10.	Compare Propofol to Fentanyl and Midazolam for Colonoscopy Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: RCCS 262, NCT01488045
11.	Performance of Endoscopic Submucosal Dissection According to the Sedation Method Phase: No phase specified Type: Health services research, Supportive care Status: Approved-not yet active Age: 20 to 80 Sponsor: Other Protocol IDs: 4-2012-0661, NCT01806753